Immune Responses to Plasmodium vivax Variant Antigens in Brazil
Author Information
Author(s): Tatiane R Oliveira, Carmen Fernandez-Becerra, Maria Carolina S Jimenez, Hernando A Del Portillo, Irene S Soares
Primary Institution: Universidade de São Paulo
Hypothesis
The study aims to evaluate the naturally-acquired immune response to Plasmodium vivax variant antigens in individuals living in malaria-endemic areas of Brazil.
Conclusion
There is a low frequency of individuals responding to each VIR antigen in endemic areas of Brazil, which may explain host susceptibility to new episodes of malaria.
Supporting Evidence
- 49% of individuals presented antibodies to at least one VIR antigen.
- Only 26% of individuals had IgG antibodies against VIR proteins.
- Antibody responses to VIR proteins were significantly lower than responses to other malaria antigens like AMA-1 and MSP119.
Takeaway
The study found that not many people in Brazil's malaria areas have strong immune responses to certain malaria proteins, which might make them more likely to get sick again.
Methodology
The study used ELISA to test serum samples for antibodies against recombinant proteins representing four VIR subfamilies in individuals with patent P. vivax malaria.
Limitations
The study was conducted in hypoendemic areas, limiting the ability to correlate antibody responses with age and previous malaria exposure.
Participant Demographics
The mean age of participants was 28.3 years, with 69.7% male, and samples were collected from various malaria-endemic regions in Brazil.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website